Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review.

Cutts JC, Agius PA, Zaw Lin, Powell R, Moore K, Draper B, Simpson JA, Fowkes FJI.

BMC Med. 2020 Jan 16;18(1):14. doi: 10.1186/s12916-019-1467-6.

2.

IgM in human immunity to Plasmodium falciparum malaria.

Boyle MJ, Chan JA, Handayuni I, Reiling L, Feng G, Hilton A, Kurtovic L, Oyong D, Piera KA, Barber BE, William T, Eisen DP, Minigo G, Langer C, Drew DR, de Labastida Rivera F, Amante FH, Williams TN, Kinyanjui S, Marsh K, Doolan DL, Engwerda C, Fowkes FJI, Grigg MJ, Mueller I, McCarthy JS, Anstey NM, Beeson JG.

Sci Adv. 2019 Sep 25;5(9):eaax4489. doi: 10.1126/sciadv.aax4489. eCollection 2019 Sep.

3.

Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.

Oyong DA, Wilson DW, Barber BE, William T, Jiang J, Galinski MR, Fowkes FJI, Grigg MJ, Beeson JG, Anstey NM, Boyle MJ.

J Infect Dis. 2019 Nov 6;220(12):1950-1961. doi: 10.1093/infdis/jiz407.

PMID:
31419296
4.

The impact of community-delivered models of malaria control and elimination: a systematic review.

Win Han Oo, Gold L, Moore K, Agius PA, Fowkes FJI.

Malar J. 2019 Aug 6;18(1):269. doi: 10.1186/s12936-019-2900-1.

5.
6.

Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.

Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, Rudan I.

Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.

7.

Ozonide Antimalarial Activity in the Context of Artemisinin-Resistant Malaria.

Giannangelo C, Fowkes FJI, Simpson JA, Charman SA, Creek DJ.

Trends Parasitol. 2019 Jul;35(7):529-543. doi: 10.1016/j.pt.2019.05.002. Epub 2019 Jun 5. Review.

8.

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.

O'Flaherty K, Ataíde R, Zaloumis SG, Ashley EA, Powell R, Feng G, Reiling L, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJI.

J Infect Dis. 2019 Aug 30;220(7):1178-1187. doi: 10.1093/infdis/jiz247.

9.

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.

Kurtovic L, Agius PA, Feng G, Drew DR, Ubillos I, Sacarlal J, Aponte JJ, Fowkes FJI, Dobaño C, Beeson JG.

BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.

10.

Targets of complement-fixing antibodies in protective immunity against malaria in children.

Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, Opi DH, Persson KEM, Richards JS, Siba PM, Fowkes FJI, Takashima E, Tsuboi T, Mueller I, Beeson JG.

Nat Commun. 2019 Feb 5;10(1):610. doi: 10.1038/s41467-019-08528-z.

11.

Effectiveness of repellent delivered through village health volunteers on malaria incidence in villages in South-East Myanmar: a stepped-wedge cluster-randomised controlled trial protocol.

Win Han Oo, Cutts JC, Agius PA, Kyaw Zayar Aung, Poe Poe Aung, Aung Thi, Nyi Nyi Zaw, Htin Kyaw Thu, Wai Yan Min Htay, Ataide R, O'Flaherty K, Ai Pao Yawn, Aung Paing Soe, Beeson JG, Crabb B, Pasricha N, Fowkes FJI.

BMC Infect Dis. 2018 Dec 14;18(1):663. doi: 10.1186/s12879-018-3566-y.

12.

Antibody Targets on the Surface of Plasmodium falciparum-Infected Erythrocytes That Are Associated With Immunity to Severe Malaria in Young Children.

Chan JA, Boyle MJ, Moore KA, Reiling L, Lin Z, Hasang W, Avril M, Manning L, Mueller I, Laman M, Davis T, Smith JD, Rogerson SJ, Simpson JA, Fowkes FJI, Beeson JG.

J Infect Dis. 2019 Feb 15;219(5):819-828. doi: 10.1093/infdis/jiy580.

PMID:
30365004
13.

In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance.

Zaloumis SG, Cao P, Dini S, Davenport MP, Cromer D, Khoury DS, Fowkes FJI, McCaw JM, Simpson JA.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01292-18. doi: 10.1128/AAC.01292-18. Print 2018 Dec.

14.

Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study.

Fowkes FJI, Moore KA, Opi DH, Simpson JA, Langham F, Stanisic DI, Ura A, King CL, Siba PM, Mueller I, Rogerson SJ, Beeson JG.

BMC Med. 2018 Sep 20;16(1):156. doi: 10.1186/s12916-018-1146-z.

15.

Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.

Dini S, Zaloumis S, Cao P, Price RN, Fowkes FJI, van der Pluijm RW, McCaw JM, Simpson JA.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01068-18. doi: 10.1128/AAC.01068-18. Print 2018 Nov.

16.

Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model.

Scott N, Ataide R, Wilson DP, Hellard M, Price RN, Simpson JA, Fowkes FJI.

Malar J. 2018 Aug 2;17(1):279. doi: 10.1186/s12936-018-2418-y.

17.

Anopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.

Ya-Umphan P, Cerqueira D, Cottrell G, Parker DM, Fowkes FJI, Nosten F, Corbel V.

Am J Trop Med Hyg. 2018 Aug;99(2):350-356. doi: 10.4269/ajtmh.18-0081. Epub 2018 May 31.

18.

Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.

Kurtovic L, Behet MC, Feng G, Reiling L, Chelimo K, Dent AE, Mueller I, Kazura JW, Sauerwein RW, Fowkes FJI, Beeson JG.

BMC Med. 2018 Apr 30;16(1):61. doi: 10.1186/s12916-018-1054-2.

19.

P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission.

McLean ARD, Stanisic D, McGready R, Chotivanich K, Clapham C, Baiwog F, Pimanpanarak M, Siba P, Mueller I, King CL, Nosten F, Beeson JG, Rogerson S, Simpson JA, Fowkes FJI.

PLoS One. 2017 Oct 13;12(10):e0186577. doi: 10.1371/journal.pone.0186577. eCollection 2017.

20.

A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.

Cao P, Klonis N, Zaloumis S, Dogovski C, Xie SC, Saralamba S, White LJ, Fowkes FJI, Tilley L, Simpson JA, McCaw JM.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00618-17. doi: 10.1128/AAC.00618-17. Print 2017 Dec.

21.

Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.

Mugyenyi CK, Elliott SR, Yap XZ, Feng G, Boeuf P, Fegan G, Osier FFH, Fowkes FJI, Avril M, Williams TN, Marsh K, Beeson JG.

J Infect Dis. 2017 Oct 17;216(7):887-898. doi: 10.1093/infdis/jix370.

22.

Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis.

Moore KA, Simpson JA, Scoullar MJL, McGready R, Fowkes FJI.

Lancet Glob Health. 2017 Nov;5(11):e1101-e1112. doi: 10.1016/S2214-109X(17)30340-6. Epub 2017 Sep 26. Review.

23.

Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study.

Ataíde R, Powell R, Moore K, McLean A, Phyo AP, Nair S, White M, Anderson TJ, Beeson JG, Simpson JA, Nosten F, Fowkes FJI.

J Infect Dis. 2017 Sep 15;216(6):723-731. doi: 10.1093/infdis/jix371.

24.

Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations.

Scott N, Hussain SA, Martin-Hughes R, Fowkes FJI, Kerr CC, Pearson R, Kedziora DJ, Killedar M, Stuart RM, Wilson DP.

Malar J. 2017 Sep 12;16(1):368. doi: 10.1186/s12936-017-2019-1.

25.
26.

Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.

Chan JA, Stanisic DI, Duffy MF, Robinson LJ, Lin E, Kazura JW, King CL, Siba PM, Fowkes FJ, Mueller I, Beeson JG.

Eur J Immunol. 2017 Dec;47(12):2124-2136. doi: 10.1002/eji.201747032. Epub 2017 Sep 13.

27.

Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar.

Draper BL, Fowkes FJI, Oo ZM, Thein ZW, Aung PP, Veronese V, Ryan C, Thant M, Hughes C, Stoové M.

J Int AIDS Soc. 2017 Jul 26;20(1):21885. doi: 10.7448/IAS.20.1.21885. Erratum in: J Int AIDS Soc. 2017;20(1):22284.

28.

Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.

Moore KA, Simpson JA, Wiladphaingern J, Min AM, Pimanpanarak M, Paw MK, Raksuansak J, Pukrittayakamee S, Fowkes FJI, White NJ, Nosten F, McGready R.

BMC Med. 2017 Jun 21;15(1):117. doi: 10.1186/s12916-017-0877-6.

29.

Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum.

McLean ARD, Boel M, McGready R, Ataide R, Drew D, Tsuboi T, Beeson JG, Nosten F, Simpson JA, Fowkes FJI.

Am J Trop Med Hyg. 2017 May;96(5):1197-1204. doi: 10.4269/ajtmh.16-0690.

30.

Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis.

Moore KA, Fowkes FJI, Wiladphaingern J, Wai NS, Paw MK, Pimanpanarak M, Carrara VI, Raksuansak J, Simpson JA, White NJ, Nosten F, McGready R.

BMC Med. 2017 May 10;15(1):98. doi: 10.1186/s12916-017-0863-z.

31.

Immunity as a predictor of anti-malarial treatment failure: a systematic review.

O'Flaherty K, Maguire J, Simpson JA, Fowkes FJI.

Malar J. 2017 Apr 20;16(1):158. doi: 10.1186/s12936-017-1815-y. Review.

32.

Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.

Ataide R, Ashley EA, Powell R, Chan JA, Malloy MJ, O'Flaherty K, Takashima E, Langer C, Tsuboi T, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJ.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3515-3520. doi: 10.1073/pnas.1615875114. Epub 2017 Mar 13.

33.

Inhibition of placental mTOR signaling provides a link between placental malaria and reduced birthweight.

Dimasuay KG, Aitken EH, Rosario F, Njie M, Glazier J, Rogerson SJ, Fowkes FJ, Beeson JG, Powell T, Jansson T, Boeuf P.

BMC Med. 2017 Jan 3;15(1):1. doi: 10.1186/s12916-016-0759-3.

35.

Peripheral artery disease: epidemiology and global perspectives.

Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH.

Nat Rev Cardiol. 2017 Mar;14(3):156-170. doi: 10.1038/nrcardio.2016.179. Epub 2016 Nov 17. Review.

PMID:
27853158
36.

Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

McCallum FJ, Persson KE, Fowkes FJ, Reiling L, Mugyenyi CK, Richards JS, Simpson JA, Williams TN, Gilson PR, Hodder AN, Sanders PR, Anders RF, Narum DL, Chitnis C, Crabb BS, Marsh K, Beeson JG.

J Leukoc Biol. 2017 Apr;101(4):913-925. doi: 10.1189/jlb.5MA0716-294R. Epub 2016 Nov 11.

37.

Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.

Chandrasiri UP, Fowkes FJ, Beeson JG, Richards JS, Kamiza S, Maleta K, Ashorn P, Rogerson SJ.

Malar J. 2016 Nov 9;15(1):547.

38.

The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.

Weaver R, Reiling L, Feng G, Drew DR, Mueller I, Siba PM, Tsuboi T, Richards JS, Fowkes FJI, Beeson JG.

Sci Rep. 2016 Sep 8;6:33094. doi: 10.1038/srep33094.

39.

Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period.

McLean AR, Boel ME, McGready R, Ataide R, Drew D, Tsuboi T, Beeson JG, Nosten F, Simpson JA, Fowkes FJ.

Sci Rep. 2016 Aug 25;6:32159. doi: 10.1038/srep32159.

40.

Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria.

Boyle MJ, Reiling L, Osier FH, Fowkes FJ.

Int J Parasitol. 2017 Feb;47(2-3):99-104. doi: 10.1016/j.ijpara.2016.06.002. Epub 2016 Jul 20. Review.

PMID:
27451359
41.

A malaria vaccine in children with HIV.

Beeson JG, Fowkes FJI.

Lancet Infect Dis. 2016 Oct;16(10):1087-1089. doi: 10.1016/S1473-3099(16)30209-2. Epub 2016 Jul 7. No abstract available.

PMID:
27394192
42.

Water, Sanitation, and Hygiene Facilities and Hygiene Practices Associated with Diarrhea and Vomiting in Monastic Schools, Myanmar.

Weaver ERN, Agius PA, Veale H, Dorning K, Hlang TT, Aung PP, Fowkes FJI, Hellard ME.

Am J Trop Med Hyg. 2016 Aug 3;95(2):278-287. doi: 10.4269/ajtmh.15-0290. Epub 2016 Jun 20.

43.

A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.

Chan JA, Howell KB, Langer C, Maier AG, Hasang W, Rogerson SJ, Petter M, Chesson J, Stanisic DI, Duffy MF, Cooke BM, Siba PM, Mueller I, Bull PC, Marsh K, Fowkes FJ, Beeson JG.

Cell Mol Life Sci. 2016 Nov;73(21):4141-58. doi: 10.1007/s00018-016-2267-1. Epub 2016 May 19.

44.

Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.

Duffy MF, Noviyanti R, Tsuboi T, Feng ZP, Trianty L, Sebayang BF, Takashima E, Sumardy F, Lampah DA, Turner L, Lavstsen T, Fowkes FJ, Siba P, Rogerson SJ, Theander TG, Marfurt J, Price RN, Anstey NM, Brown GV, Papenfuss AT.

Malar J. 2016 May 5;15(1):258. doi: 10.1186/s12936-016-1296-4.

45.

Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.

Moore KA, Simpson JA, Paw MK, Pimanpanarak M, Wiladphaingern J, Rijken MJ, Jittamala P, White NJ, Fowkes FJI, Nosten F, McGready R.

Lancet Infect Dis. 2016 May;16(5):576-583. doi: 10.1016/S1473-3099(15)00547-2. Epub 2016 Feb 8. Erratum in: Lancet Infect Dis. 2016 May;16(5):521.

46.

Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting.

Charnaud SC, McGready R, Herten-Crabb A, Powell R, Guy A, Langer C, Richards JS, Gilson PR, Chotivanich K, Tsuboi T, Narum DL, Pimanpanarak M, Simpson JA, Beeson JG, Nosten F, Fowkes FJ.

Sci Rep. 2016 Feb 10;6:20859. doi: 10.1038/srep20859.

47.

Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria.

Beeson JG, Drew DR, Boyle MJ, Feng G, Fowkes FJ, Richards JS.

FEMS Microbiol Rev. 2016 May;40(3):343-72. doi: 10.1093/femsre/fuw001. Epub 2016 Jan 31. Review.

48.

Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task.

Simpson JA, McCaw J, Fowkes FJ.

Antimicrob Agents Chemother. 2016 Jan 29;60(2):1172. doi: 10.1128/AAC.02528-15. Print 2016 Feb. No abstract available.

49.

Immunity to malaria in an era of declining malaria transmission.

Fowkes FJ, Boeuf P, Beeson JG.

Parasitology. 2016 Feb;143(2):139-53. doi: 10.1017/S0031182015001249. Epub 2016 Jan 7. Review.

PMID:
26741253
50.

Malaria eradication and elimination: views on how to translate a vision into reality.

Tanner M, Greenwood B, Whitty CJ, Ansah EK, Price RN, Dondorp AM, von Seidlein L, Baird JK, Beeson JG, Fowkes FJ, Hemingway J, Marsh K, Osier F.

BMC Med. 2015 Jul 25;13:167. doi: 10.1186/s12916-015-0384-6.

Supplemental Content

Loading ...
Support Center